Quantum BioPharma Ltd.

DB:0K91 Voorraadrapport

Marktkapitalisatie: €8.0m

Quantum BioPharma Beheer

Beheer criteriumcontroles 4/4

Quantum BioPharma's CEO is Zeeshan Saeed, appointed in Jul 2021, has a tenure of 3.33 years. total yearly compensation is $599.87K, comprised of 37.1% salary and 62.9% bonuses, including company stock and options. directly owns 6.29% of the company’s shares, worth €505.28K. The average tenure of the management team and the board of directors is 3.2 years and 3.2 years respectively.

Belangrijke informatie

Zeeshan Saeed

Algemeen directeur

US$599.9k

Totale compensatie

Percentage CEO-salaris37.1%
Dienstverband CEO3.3yrs
Eigendom CEO6.3%
Management gemiddelde ambtstermijn3.2yrs
Gemiddelde ambtstermijn bestuur3.2yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Zeeshan Saeed's beloning veranderd ten opzichte van Quantum BioPharma's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-US$7m

Mar 31 2024n/an/a

-US$10m

Dec 31 2023US$600kUS$223k

-US$18m

Sep 30 2023n/an/a

-US$23m

Jun 30 2023n/an/a

-US$29m

Mar 31 2023n/an/a

-US$31m

Dec 31 2022US$774kUS$239k

-US$27m

Sep 30 2022n/an/a

-US$27m

Jun 30 2022n/an/a

-US$25m

Mar 31 2022n/an/a

-US$30m

Dec 31 2021US$1mUS$225k

-US$34m

Sep 30 2021n/an/a

-US$32m

Jun 30 2021n/an/a

-US$39m

Mar 31 2021n/an/a

-US$30m

Dec 31 2020US$899kUS$212k

-US$28m

Sep 30 2020n/an/a

-US$36m

Jun 30 2020n/an/a

-US$35m

Mar 31 2020n/an/a

-US$41m

Dec 31 2019US$2mUS$249k

-US$34m

Sep 30 2019n/an/a

-US$38m

Jun 30 2019n/an/a

-US$25m

Mar 31 2019n/an/a

-US$16m

Dec 31 2018US$503kUS$183k

-US$17m

Compensatie versus markt: Zeeshan's total compensation ($USD599.87K) is about average for companies of similar size in the German market ($USD488.36K).

Compensatie versus inkomsten: Zeeshan's compensation has been consistent with company performance over the past year.


CEO

Zeeshan Saeed (54 yo)

3.3yrs

Tenure

US$599,873

Compensatie

Mr. Zeeshan Saeed serves as Executive Co-Chairman at FSD Pharma Inc. since May 24, 2018 and serves as its President since July 27, 2021 and Chief Executive Officer since June 29, 2023. He serves as Co-Chai...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Zeeshan Saeed
Founder3.3yrsUS$599.87k6.29%
€ 505.3k
Anthony Durkacz
Founder & Executive Co-Chairman6.4yrsUS$599.87k5.36%
€ 431.1k
Donal Carroll
CFO & COO3.3yrsUS$602.87k4.44%
€ 356.6k
Nathan Coyle
Controllerless than a yearUS$178.21k0.13%
€ 10.8k
Lakshmi Kotra
CEO of Lucid & Director3.2yrsUS$521.97k1.17%
€ 94.3k
Jason Sawyer
Head of Finance & Mergers and Acquisitionsless than a yeargeen gegevensgeen gegevens
Maryann Adesso
Corporate Secretaryno datageen gegevensgeen gegevens
Randell Mack
President of FSD BioSciences3.7yrsgeen gegevensgeen gegevens
Andrzej Chruscinski
Vice President of Clinical & Scientific Affairs of Lucidno dataUS$110.30k0%
€ 0
Kevin Cassidy
Vice President of Quality-Lucidno dataUS$144.82kgeen gegevens

3.2yrs

Gemiddelde duur

48yo

Gemiddelde leeftijd

Ervaren management: 0K91's management team is considered experienced (3.2 years average tenure).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Zeeshan Saeed
Founder3.5yrsUS$599.87k6.29%
€ 505.3k
Anthony Durkacz
Founder & Executive Co-Chairman6.4yrsUS$599.87k5.36%
€ 431.1k
Lakshmi Kotra
CEO of Lucid & Director2yrsUS$521.97k1.17%
€ 94.3k
Daniele Piomelli
Member of Research & Clinical Advisory Board2.8yrsgeen gegevensgeen gegevens
Eleanor Fish
Member of Research & Clinical Advisory Board3yrsgeen gegevensgeen gegevens
Hance Clarke
Member of Research & Clinical Advisory Board3.2yrsgeen gegevensgeen gegevens
Eric Hoskins
Independent Director1.5yrsgeen gegevensgeen gegevens
Adnan Bashir
Independent Director3.4yrsUS$139.37k0.0077%
€ 620.5
Peter Stys
Member of Research & Clinical Advisory Board3.2yrsgeen gegevensgeen gegevens
Shannon Dunn
Member of Research & Clinical Advisory Board3.2yrsgeen gegevensgeen gegevens
Albert Wong
Member of Research & Clinical Advisory Board3.2yrsgeen gegevensgeen gegevens
Joga Gobburu
Member of Regulatory Advisory Board3yrsgeen gegevensgeen gegevens

3.2yrs

Gemiddelde duur

54yo

Gemiddelde leeftijd

Ervaren bestuur: 0K91's board of directors are considered experienced (3.2 years average tenure).